Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage.
Leukocyte-endothelial cell interactions appear to be the root cause of chronic vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). Early clinical observations and indirect experimental evidence suggested an association between inflammation and chronic vasospasm. Early clinical observations in patients with post-hemorrhagic vasospasm included pyrexia, leukocytosis and the presence of circulating immune complexes. Inflammatory infiltrates and increased levels of immunoglobulins and complement fractions within spastic cerebral arteries also provided early evidence for an inflammatory mechanism underlying chronic vasospasm. Early indirect experimental evidence included the ability to reproduce chronic vasospasm with the introduction of inflammatory agents into the subarachnoid space and the inhibition of vasospasm with anti-inflammatory agents. Currently, however, there is an increasing body of direct molecular evidence that demonstrates the pivotal role of leukocyte-endothelial cell interactions in the development of chronic vasospasm. Cell adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1), lymphocyte function-associated antigen-1 (LFA-1), macrophage antigen-1 (Mac-1) and endothelial (E)-selectin mediate interactions between circulating leukocytes and cerebral endothelium. Following aSAH, ICAM-1 is up-regulated in cerebral endothelial cells and along with other cell adhesion molecules, can be detected in the serum and cerebrospinal fluid (CSF) of patients with post-hemorrhagic vasospasm. Monoclonal antibody blocking experiments have demonstrated that the prevention of leukocyte extravasation into the subarachnoid space prevents chronic vasospasm. Similarly, drugs like ibuprofen, which prevent ICAM-1 up-regulation and transendothelial cell migration of leukocytes, prevent vasospasm. In this review, we highlight early observations that suggested an association between inflammation and post-hemorrhagic vasospasm, detail the role of leukocyte-endothelial cell interactions in the development of chronic vasospasm and discuss therapeutic implications of an inflammatory etiology of post-hemorrhagic cerebral vasospasm.
Gallia
Gary L
GL
Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Tamargo
Rafael J
RJ
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002450:Cell Communication / Q000187:drug effects / Q000502:physiology; D002536:Cerebral Arteries / Q000378:metabolism / Q000503:physiopathology*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects / Q000502:physiology; D042783:Endothelial Cells / Q000378:metabolism; D006801:Humans; D007962:Leukocytes / Q000378:metabolism*; D013345:Subarachnoid Hemorrhage / Q000150:complications*; D014657:Vasculitis / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control; D020301:Vasospasm, Intracranial / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology*
D000893:Anti-Inflammatory Agents; D015815:Cell Adhesion Molecules